Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Glucagon receptor | ||
Ligand | BDBM50171818 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_321434 (CHEMBL880242) | ||
IC50 | 3.2±n/a nM | ||
Citation | Shen, DM; Zhang, F; Brady, EJ; Candelore, MR; Dallas-Yang, Q; Ding, VD; Dragovic, J; Feeney, WP; Jiang, G; McCann, PE; Mock, S; Qureshi, SA; Saperstein, R; Shen, X; Tamvakopoulos, C; Tong, X; Tota, LM; Wright, MJ; Yang, X; Zheng, S; Chapman, KT; Zhang, BB; Tata, JR; Parmee, ER Discovery of novel, potent, and orally active spiro-urea human glucagon receptor antagonists. Bioorg Med Chem Lett15:4564-9 (2005) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Glucagon receptor | |||
Name: | Glucagon receptor | ||
Synonyms: | GCGR | GL-R | GLR_HUMAN | Glucagon Receptor (GCGR) | Glucagon receptor (GlucR) | ||
Type: | Enzyme | ||
Mol. Mass.: | 54026.92 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P47871 | ||
Residue: | 477 | ||
Sequence: |
| ||
BDBM50171818 | |||
n/a | |||
Name | BDBM50171818 | ||
Synonyms: | 4-[1-(4-tert-Butyl-cyclohexyl)-3-(4-trifluoromethoxy-phenyl)-ureidomethyl]-N-(1H-tetrazol-5-yl)-benzamide | CHEMBL196800 | ||
Type | Small organic molecule | ||
Emp. Form. | C27H32F3N7O3 | ||
Mol. Mass. | 559.5833 | ||
SMILES | CC(C)(C)C1CCC(CC1)N(Cc1ccc(cc1)C(=O)Nc1nnn[nH]1)C(=O)Nc1ccc(OC(F)(F)F)cc1 |(-1.28,-4.62,;-2.05,-3.29,;-2.82,-1.94,;-3.4,-4.04,;-.72,-2.5,;.17,-.87,;1.62,-1.75,;4.02,-1.82,;2.92,-2.9,;2.08,-2.5,;5.35,-2.59,;5.35,-4.13,;6.68,-4.88,;6.68,-6.44,;8.01,-7.21,;9.34,-6.44,;9.34,-4.88,;8.01,-4.11,;10.69,-7.21,;10.69,-8.75,;12.02,-6.42,;13.35,-7.19,;14.85,-6.84,;15.64,-8.14,;14.66,-9.32,;13.24,-8.73,;6.68,-1.8,;6.68,-.26,;8.01,-2.57,;9.34,-1.8,;9.34,-.28,;10.67,.49,;12,-.28,;13.33,.49,;14.68,-.26,;13.89,-1.59,;16.01,-1.03,;15.43,1.07,;12,-1.82,;10.67,-2.59,)| | ||
Structure |